Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Charting a New Course Post-PHE

From the College  |  May 23, 2023

On May 11, the public health emergency (PHE) expired following three years of flexibility and changes within the healthcare system. So, what has changed for providers and patients?  

Cost-Sharing of COVID-19 Vaccines & Treatments

Testing

During the PHE, the federal government purchased all coronavirus vaccines and laboratory tests to allow greater access to these treatments. Upon the expiration of the PHE, health plans, including Medicare Advantage plans, will be permitted to require cost-sharing for these services. Medicare will continue to cover these tests, as it does for all clinical diagnostic testing, if they are ordered by a provider.  

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Vaccines

The federal government has purchased 1.2 billion doses of Pfizer and Moderna vaccines. Until the federally purchased doses are exhausted, COVID vaccines will continue to be free of cost to all. Once this supply has diminished, vaccines will be transitioned to the traditional health market. The Centers for Medicare & Medicaid Services (CMS) expect to set payment rates for the administration of the vaccine to align with other Part B vaccines. Beneficiaries with private health insurance will likely continue to have the vaccine covered as part of the CDC Vaccine Guidance. The CMS has established a bridge access program for uninsured patients to continue to have access to vaccines. 

Telehealth Flexibilities Are Largely Unchanged 

Telehealth Continues Through 2024

Telehealth has expanded exponentially since the beginning of the pandemic in 2020. In fact, the Centers for Medicare & Medicaid Services (CMS) has indicated in rulemaking that it is considering which flexibilities will become permanent following the PHE. The Consolidated Appropriations Act of 2023 extended most telehealth flexibilities until December 31, 2024. This extension includes:

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE
  • Geographic flexibility, allowing patients to receive care anywhere rather than a designated rural or clinic setting;
  • Continuation of evaluation and management (E/M) visits;
  • Continuation of audio-only visits; and
  • Continuation of expanded qualifying providers (g. physical therapists, occupational therapists and speech pathologists).

What May Require Additional Policymaking

Current regulations and statutes allow for reimbursement for telehealth visits (both audio-visual and audio-only) to ensure parity payment after December 31, 2023. The ACR expects to see more on this issue in the upcoming Medicare Physician Fee Schedule.

HIPAA-Compliance of Platforms Now Required

Upon the expiration of the PHE, all telehealth visits must be performed via a HIPAA-compliant platform. During the initial stages of the pandemic, the Department of Health & Human Services Office of Civil Rights (OCR) used enforcement desecration on HIPAA violations for telehealth platforms, which allowed visits to occur over commercial platforms, such as FaceTime and Zoom. Now, however, all telehealth visits must occur on HIPAA-compliant platforms. The OCR has indicated it will resume enforcement related to the use of any non-compliant platforms.

Page: 1 2 | Single Page
Share: 

Filed under:Practice Support Tagged with:COVID-19telehealthU.S. public health emergency

Related Articles

    What’s Next for Telehealth after the COVID-19 Public Health Emergency?

    June 10, 2023

    Do you remember where you were when the COVID-19 Public Health Emergency (PHE) was declared on Jan. 31, 2020? While it may seem like yesterday, you would be forgiven for not recalling your exact location over three years ago during what felt like an incredible whirlwind for the healthcare industry. One possible location you may…

    HHS Secretary Xavier Becerra Extends Public Health Emergency

    April 16, 2021

    The COVID-19 public health emergency (PHE) has been extended, effective April 21. The Biden administration has indicated it will likely extend the PHE through the end of the year.

    The Pandemic’s End: What Do the Ending National Emergency Proclamations Mean for Healthcare?

    April 21, 2023

    As COVID-19 case counts fade from the headlines and people return to their pre-pandemic routines, rheumatologists and rheumatology professionals may be wondering what “the end” of COVID-19 is going to look like for them. Much of that answer lies in the status of the federal emergencies that have been declared in response to COVID-19. These…

    Telerheumatology: What’s Next?

    December 17, 2020

    In an ACR Convergence session, two rheumatologists discussed how COVID-19 changed the use of telemedicine, how payers reacted and which changes are likely permanent and which are likely to be temporary.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences